Patient's own stem cells may help angina
Posted on: Monday, 30 March 2009, 13:02 CDT
A U.S. study has shown the first evidence that stem cells taken from a patient suffering severe angina and placed into that patient's heart may lessen pain.
The data came from a six-month, Phase II study led by Dr. Douglas Losordo at Northwestern University's Feinberg School of Medicine and director of the Program in Cardiovascular Regenerative Medicine at Northwestern Memorial Hospital.
The results from this study provide the first evidence that a patient's own stem cells could actually be used as a treatment for their heart disease,
said Losordo, a professor at the school. The study provides potential hope for those patients with currently untreatable angina to be more active with less pain.
Losordo cautioned the findings of the 26-site trial, while encouraging, are not yet definitive and require verification in a larger study. Northwestern Memorial Hospital was the lead site of the study that involved 167 adult patients.
The findings were presented Saturday in Orlando, Fla., during the American College of Cardiology's 58th annual scientific session.
Source: United Press International
Related Articles
- SAPHRIS(R) (asenapine) Meets Primary Endpoint in Long-Term Extension Study in Patients With Predominant, Persistent Negative Symptoms of Schizophrenia
- Results From Largest Statin Study of Patients With Alzheimer's Disease Show Lipitor(R) Has No Significant Impact on Disease
- Results of Sepracor's LUNESTA(R) Next-Day Driving Study in Patients With Primary Insomnia Presented at American College of Neuropsychopharmacology Meeting
- ZymoGenetics Releases Preliminary Findings From Atacicept (TACI-Ig) Phase 1b Studies in Patients With Lupus
- Rigel Announces Completion of R788 Plus Methotrexate Drug Interaction Study in Patients With Rheumatoid Arthritis
- Web Seminar Offered -- ''EHR Case Study: Delivering Patient Data Today''
- ZymoGenetics Reports Preliminary Positive Results From TACI-Ig Phase 1b Study in Patients With Rheumatoid Arthritis
- New Study Suggests Patients With Schizophrenia Improved With Treatment Change to RISPERDAL(R) CONSTA(R)
- IL-1 Trap Shows Positive Results in Study of Patients With Inflammatory Disease
- Updated Survival Results From BLP25 Liposome Vaccine (L-BLP25) Phase IIb Study From Patients With Stage IIIB Non-Small Cell Lung Cancer (NSCLC) Presented
 |
 |
User Comments (0)
RSS Feeds